Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome

Published:2016-02 Issue:4 Volume:67 Page:353-361
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Murphy Sabina A.,Cannon Christopher P.,Blazing Michael A.,Giugliano Robert P.,White Jennifer A.,Lokhnygina Yuliya,Reist Craig,Im KyungAh,Bohula Erin A.,Isaza Daniel,Lopez-Sendon Jose,Dellborg Mikael,Kher Uma,Tershakovec Andrew M.,Braunwald Eugene

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes

2. Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial;Tikkanen;J Am Coll Cardiol,2009

3. Ezetimibe added to statin therapy after acute coronary syndromes;Cannon;N Engl J Med,2015

4. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes;Cannon;Am Heart J,2008

5. Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population;Blazing;Am Heart J,2014

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Primordial, Primary, and Secondary Prevention of Stroke in Diverse Populations;Stroke;2024-09

2. ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction;Journal of the American College of Cardiology;2024-09

3. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases;European Heart Journal;2024-08-30

4. The Imperative to Enhance Cost-Effectiveness for Cardiovascular Therapeutic Development;JACC: Basic to Translational Science;2024-08

5. Evolution of LDL-C lowering medications and their cardiovascular benefits: Past, present, and future;Current Problems in Cardiology;2024-07